H.B. Fuller (NYSE:FUL – Get Rating) updated its FY23 earnings guidance on Wednesday. The company provided earnings per share guidance of $4.15-$4.55 for the period, compared to the consensus earnings per share estimate of $4.63. The company issued revenue guidance of $3.64-$3.75 billion, compared to the consensus revenue estimate of $3.94 billion.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the company. Deutsche Bank Aktiengesellschaft increased their price target on H.B. Fuller from $72.00 to $78.00 in a research report on Friday. StockNews.com assumed coverage on H.B. Fuller in a research report on Wednesday, October 12th. They set a hold rating for the company. Finally, Robert W. Baird dropped their price objective on H.B. Fuller from $85.00 to $80.00 and set an outperform rating on the stock in a research note on Friday. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of Hold and a consensus price target of $71.25.
Get
H.B. Fuller alerts:
H.B. Fuller Price Performance
NYSE:FUL opened at $68.85 on Friday. The firm has a market capitalization of $3.67 billion, a price-to-earnings ratio of 19.29 and a beta of 1.54. The company has a quick ratio of 1.18, a current ratio of 1.93 and a debt-to-equity ratio of 1.19. H.B. Fuller has a 12-month low of $57.36 and a 12-month high of $81.41. The stock's 50 day moving average price is $75.23 and its two-hundred day moving average price is $68.52.
Insider Transactions at H.B. Fuller
In other news, VP Timothy J. Keenan sold 9,154 shares of the stock in a transaction that occurred on Monday, October 31st. The stock was sold at an average price of $69.92, for a total transaction of $640,047.68. Following the transaction, the vice president now owns 22,871 shares in the company, valued at $1,599,140.32. The sale was disclosed in a filing with the SEC, which is available through
the SEC website. In other H.B. Fuller news, CEO James Owens sold 79,061 shares of the firm's stock in a transaction on Monday, November 7th. The stock was sold at an average price of $71.07, for a total value of $5,618,865.27. Following the sale, the chief executive officer now owns 163,703 shares of the company's stock, valued at approximately $11,634,372.21. The sale was disclosed in a document filed with the SEC, which is available at
the SEC website. Also, VP Timothy J. Keenan sold 9,154 shares of the firm's stock in a transaction on Monday, October 31st. The shares were sold at an average price of $69.92, for a total value of $640,047.68. Following the completion of the sale, the vice president now directly owns 22,871 shares in the company, valued at approximately $1,599,140.32. The disclosure for this sale can be found
here. Over the last quarter, insiders have sold 200,357 shares of company stock worth $14,707,214. Company insiders own 4.69% of the company's stock.
Institutional Investors Weigh In On H.B. Fuller
A number of large investors have recently modified their holdings of FUL. Eagle Bay Advisors LLC acquired a new stake in shares of H.B. Fuller during the 2nd quarter valued at $33,000. Marshall Wace LLP acquired a new position in H.B. Fuller during the 3rd quarter worth about $701,000. Teachers Retirement System of The State of Kentucky acquired a new position in H.B. Fuller during the 3rd quarter worth about $996,000. MetLife Investment Management LLC lifted its holdings in H.B. Fuller by 55.7% during the 1st quarter. MetLife Investment Management LLC now owns 27,833 shares of the specialty chemicals company's stock worth $1,839,000 after buying an additional 9,960 shares during the period. Finally, BNP Paribas Arbitrage SNC lifted its holdings in H.B. Fuller by 105.8% during the 3rd quarter. BNP Paribas Arbitrage SNC now owns 32,200 shares of the specialty chemicals company's stock worth $1,935,000 after buying an additional 16,553 shares during the period. Institutional investors and hedge funds own 96.53% of the company's stock.
H.B. Fuller Company Profile
(Get Rating)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Further Reading
- Get a free copy of the StockNews.com research report on H.B. Fuller (FUL)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
